Skip to content

A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

A Comparison of Diabetes Group Education as Administered Through Telemedicine Versus as Administered in Person

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00629434
Enrollment
68
Registered
2008-03-06
Start date
2001-06-30
Completion date
2008-08-31
Last updated
2021-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes Education, Telemedicine

Brief summary

This study compares group diabetes education in-person versus via telemedicine

Detailed description

Diabetes education is important in the treatment of the person with diabetes. A diabetes self-management education program not only educates the patient and his/her family to the basics of diabetes care but also integrates diabetes care into daily life while providing coping skills to adjust to this chronic illness. Unfortunately, comprehensive diabetes care is not available to all persons with diabetes. One obstacle to the provision of comprehensive diabetes care is the unavailability of a diabetes treatment center. many people with diabetes live too far or do not have the transportation to be able to attend education programs that met national standards. We have shown that telemedicine is an effective means to provide comprehensive 1:1 individualized diabetes education to persons with diabetes. We now propose to test the hypothesis that diabetes groups education classes can be provided effectively through telemedicine technology to individuals living in rural areas. Patients with diabetes will received diabetes education via teleconferencing from our Joslin Diabetes center. The participants will be assessed before and after diabetes education via telemedicine using measures of glycemia (A1c) and assessments of patient satisfaction, emotional well being, and behavioral change and compared to results from participants attending our diabetes education classes in-person.

Interventions

OTHERdiabetes education via telemedicine

This arm will receive diabetes group education via telemedicine

OTHERdiabetes education in-person

In this arm the group of patients with diabetes will receive diabetes education in-person

Sponsors

State University of New York - Upstate Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Type 1 or type 2 diabetes mellitus * age \> 18 years

Exclusion criteria

* Profound vision loss * Severe hearing impairment

Design outcomes

Primary

MeasureTime frame
A1cbaseline, 3 mo post intervention, 6 mo post intervention

Secondary

MeasureTime frame
PAID scalebaseline, 3 and 6 months post intervention
Diabetes Treatment Satisfaction QuestionnaireBaseline, 3 and 6 months post intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026